Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat ...

Persistence of high EBNA-1 titers across longitudinal samples was characteristic of MS, whereas MOGAD and NMOSD generally exhibited titer attenuation during follow-up. High-level EBNA-1 positivity in ...

The breakthrough treatment could lead to safer cancer therapies and may also help treat autoimmune diseases like lupus ...

The Adapt Oculus trial is unique in that it includes a patient population often overlooked in clinical trials, patients ...

A shot that keeps a mare from getting pregnant sounds simple. In practice, it is one of the messier problems in wildlife management, where every extra dose means another chase, another dart, another ...

Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore is presenting ...

She notes that for an average 85- to 90-pound calf, four liters is probably appropriate. But not every calf falls into that ...

To ensure young calves get off on the right foot after they hit the ground, push colostrum, monitor the umbilical cord, ...

Objective A panel of antibodies against three antigens, University Hasselt (UH)-rheumatoid arthritis (RA).305, 318 and 329, has been associated with lack of response to first-line therapy in the Care ...

For more than a century, the human appendix has been written off as a biological relic, a shrunken leftover from plant-eating ancestors that serves no real purpose. That view is now outdated. A ...

Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable ...